{"id":"W3213530550","doi":"10.25251/skin.5.supp.53","title":"Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial","year":2021,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma","keywords":"Secukinumab; Medicine; Plaque psoriasis; Double blinded; Psoriasis; Dermatology; Randomized controlled trial; Multicenter study; Internal medicine; Psoriatic arthritis; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395673,0.0004035874,0.001389019,0.00009335079,0.0003355202,0.00002477744,0.000596169,0.0002300807,0.0002146389],"category_scores_gemma":[0.001154834,0.0001848588,0.0003157891,0.0003244456,0.0004451131,0.00008455113,0.00009102323,0.0005166255,0.00001684091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001027132,"about_ca_system_score_gemma":0.0002617429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003421354,"about_ca_topic_score_gemma":0.0003505372,"domain_scores_codex":[0.9961094,0.001359679,0.001406105,0.0003124914,0.0003415475,0.0004707739],"domain_scores_gemma":[0.9922174,0.00517696,0.001233706,0.0006495718,0.0006161959,0.0001062301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9675999,0.001140934,0.00001169997,0.00000709427,0.003645474,0.0003320462,0.01458585,0.0003087055,0.00119083,0.00001268461,0.001585545,0.009579252],"study_design_scores_gemma":[0.9731495,0.003877596,0.00007925436,0.0003197844,0.002530049,0.0006208628,0.002367964,0.00001530132,0.01434082,0.00002778458,0.002459779,0.0002112518],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878764,0.002930787,0.00009395365,0.002920028,0.004033685,0.001409685,0.0006193281,0.00001456142,0.000101626],"genre_scores_gemma":[0.997697,0.0007686467,0.0001012501,0.0002616862,0.0005900377,0.00001467237,0.0003121941,0.00003480096,0.0002196948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01314999,"threshold_uncertainty_score":0.7538325,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02891430811388028,"score_gpt":0.2928783056741451,"score_spread":0.2639639975602648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}